Clyburn Frank — SEC Form 4 filings
SEC reporting owner CIK 1763963. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-05 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Director | 4 | — | — | 7 |
| Cencora, Inc. (COR) | Director | 3 | — | — | 3 |
| INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) | Chief Executive Officer | 1 | — | — | 3 |
| Kailera Therapeutics, Inc. (KLRA) | Director | 1 | — | — | 1 |
Form 4 filings — Clyburn Frank
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | Kailera Therapeutics, Inc. (KLRA) | Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Cencora, Inc. (COR) | Grant/award (A): 557 @ $359.28 | EDGAR |
| 2025-06-30 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 2,806 @ $0 · Grant/award (A): 10,337 (derivative) @ $0 | EDGAR |
| 2025-04-28 | 4/A | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 26,540 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Cencora, Inc. (COR) | Grant/award (A): 789 | EDGAR |
| 2024-11-05 | 4 | Cencora, Inc. (COR) | Grant/award (A): 368 @ $234.27 | EDGAR |
| 2024-08-07 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 6,932 @ $0 · Grant/award (A): 27,744 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) | Option exercise (M): 1,324 @ $0 · Tax withholding (F): 323 @ $75.88 · Option exercise (M): 1,324 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1763963 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →